See Stability for additional info
Additionally, GLP-1R agonists inhibit tau protein hyperphosphorylation, promote the release of brain-derived neurotrophic factor, and reduce neuroinflammatory responses by inhibiting microglial and astrocyte activation [55,56,57]
The absence of regulatory oversight means users cannot be certain of what they are actually receiving, even if the product label claims to contain BPC-157
Each capsule contains 100 mg of S-acetyl-glutathione
Neither has been tested in humans, and both carry significant unknowns -- Dihexa with its retracted publication and oncological pathway concerns, PE-22-28 with its untested cognitive effects and potential seizure susceptibility
Moossavi S, Besharat S, Sharafkhah M, et al